The influence of surface active substances on alveolar mechanics in the respiratory distress syndrome.
D000818:Animals; D004285:Dogs; D004548:Elasticity; D005260:Female; D006801:Humans; D006819:Hyaline Membrane Disease / Q000503:physiopathology*; D007231:Infant, Newborn; D008074:Lipoproteins; D008168:Lung / Q000502:physiology*; D008170:Lung Compliance; D010743:Phospholipids / Q000032:analysis* / Q000494:pharmacology; D011650:Pulmonary Alveoli / Q000503:physiopathology*; D001261:Pulmonary Atelectasis / Q000503:physiopathology; D012127:Respiratory Distress Syndrome, Newborn / Q000503:physiopathology*; D013500:Surface Tension; D013501:Surface-Active Agents; D013552:Swine
D008074:Lipoproteins; D010743:Phospholipids; D013501:Surface-Active Agents